BioTechGrid

The race to enhance quantum computing technology has taken a significant turn with the development of an innovative quantum refrigerator…

In the wake of the 2015 emissions scandal that shook the automotive industry, the conversation around realistic vehicle emissions testing…

Eliem Therapeutics is continuing its transformation into an immune-mediated disease company by paying $9 million to license a Chinese biotech’s…

The J.P. Morgan Healthcare Conference in San Francisco is back for 2025 and here at Fierce Biotech, we’re going to…

Bayer’s hot flash drug candidate has hit the mark in a phase 3 breast cancer trial, potentially positioning the German drugmaker…

On Astellas Pharma’s mission to develop new cell therapies in cancers and other diseases, not all candidates are destined to…

Deep in the realms of aerospace engineering, a groundbreaking study is taking shape, one that could potentially redefine how we…

A phase 3 trial of MaaT Pharma’s graft-versus-host disease (GvHD) drug candidate has hit its primary endpoint, positioning the biotech to…

Velia Therapeutics has announced it is winding down its operations while staying loyal to the therapeutic potential of microproteins. Founded…

With its dwindling cash reserves set to run out this month, Windtree Therapeutics had looked like it was struggling to…